Search by Drug Name or NDC
NDC 68462-0585-76 Aprepitant 125 mg/1 Details
Aprepitant 125 mg/1
Aprepitant is a ORAL CAPSULE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Glenmark Pharmaceuticals Inc., USA. The primary component is APREPITANT.
MedlinePlus Drug Summary
Aprepitant is used with other medications in adults and children 6 months of age and older to prevent nausea and vomiting that may occur after receiving cancer chemotherapy treatment. It is also used with other medications in adults and children 6 months of age and older to prevent delayed nausea and vomiting that may occur several days after receiving certain chemotherapy medications. Aprepitant is not used to treat nausea and vomiting that you already have. Aprepitant is in a class of medications called antiemetics. It works by blocking the action of neurokinin, a natural substance in the brain that causes nausea and vomiting.
Related Packages: 68462-0585-76Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Aprepitant
Product Information
| NDC | 68462-0585 |
|---|---|
| Product ID | 68462-585_7afb84b5-c519-4774-a8ce-099011b09a6b |
| Associated GPIs | 50280020000130 |
| GCN Sequence Number | 051912 |
| GCN Sequence Number Description | aprepitant CAPSULE 125 MG ORAL |
| HIC3 | H6J |
| HIC3 Description | ANTIEMETIC/ANTIVERTIGO AGENTS |
| GCN | 19366 |
| HICL Sequence Number | 025058 |
| HICL Sequence Number Description | APREPITANT |
| Brand/Generic | Generic |
| Proprietary Name | Aprepitant |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Aprepitant |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | CAPSULE |
| Route | ORAL |
| Active Ingredient Strength | 125 |
| Active Ingredient Units | mg/1 |
| Substance Name | APREPITANT |
| Labeler Name | Glenmark Pharmaceuticals Inc., USA |
| Pharmaceutical Class | Cytochrome P450 2C9 Inducers [MoA], Cytochrome P450 3A4 Inducers [MoA], Cytochrome P450 3A4 Inhibitors [MoA], Neurokinin 1 Antagonists [MoA], Substance P/Neurokinin-1 Receptor Antagonist [EPC] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA207777 |
| Listing Certified Through | 2025-12-31 |
Package
NDC 68462-0585-76 (68462058576)
| NDC Package Code | 68462-585-76 |
|---|---|
| Billing NDC | 68462058576 |
| Package | 1 BLISTER PACK in 1 CARTON (68462-585-76) / 6 CAPSULE in 1 BLISTER PACK |
| Marketing Start Date | 2017-10-12 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |